Drug Development

UCB and Microsoft expand drug development partnership

25th February 2021

UCB and Microsoft have entered into a new multi-year, strategic collaboration. The collaboration will merge Microsoft’s computational services, Cloud and...

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

by Content Team

14th February 2021

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer's disease

Exscientia, a leading AI Drug Discovery company, has announced its collaboration with the Alzheimer’s Research UK University of Oxford Drug...

PDA to Collaborate with Deloitte and U.S. FDA to Improve the Quality of Compounded Drugs

by Content Team

14th February 2021

PDA to Collaborate with Deloitte and U.S. FDA to Improve the Quality of Compounded Drugs

The Parenteral Drug Association (PDA) announced it has signed an agreement to collaborate with Deloitte Consulting, LLP and the U.S....

AstraZeneca and IDT Biologika sign LOI to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

by Content Team

14th February 2021

Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma

EMA approval, millions of AstraZeneca vaccines began shipping on 5 February as part of the initial 17m doses that are...

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

by Content Team

14th February 2021

Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials...

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

by Content Team

14th February 2021

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has decided to review its...

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

by Content Team

12th February 2021

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials...

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

by Content Team

4th February 2021

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study...

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

by Content Team

4th February 2021

Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation...